{
  "trial_id": "NCT00663260",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, baseline HbA1c, baseline fasting plasma glucose, duration of diabetes, body mass index (BMI), estimated glomerular filtration rate (eGFR), blood pressure, lipid profile, renal function markers (e.g., serum creatinine), concomitant medications, race/ethnicity, smoking status, history of cardiovascular disease.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex/Gender",
          "gender"
        ],
        [
          "Race/Ethnicity",
          "race/ethnicity"
        ]
      ],
      "remaining_reference_features": [
        "Weight",
        "Pre-Enrollment Anti-Hyperglycemic Therapy"
      ],
      "remaining_candidate_features": [
        "baseline HbA1c",
        "baseline fasting plasma glucose",
        "duration of diabetes",
        "body mass index (BMI)",
        "estimated glomerular filtration rate (eGFR)",
        "blood pressure",
        "lipid profile",
        "renal function markers (e.g., serum creatinine)",
        "concomitant medications",
        "smoking status",
        "history of cardiovascular disease"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline HbA1c, Body Mass Index, Serum Creatinine, Estimated Glomerular Filtration Rate (eGFR), Duration of Diabetes, Systolic Blood Pressure, Diastolic Blood Pressure,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex/Gender",
          "Sex: Female"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ]
      ],
      "remaining_reference_features": [
        "Weight",
        "Pre-Enrollment Anti-Hyperglycemic Therapy"
      ],
      "remaining_candidate_features": [
        "Male",
        "Region of Enrollment",
        "Baseline HbA1c",
        "Body Mass Index",
        "Serum Creatinine",
        "Estimated Glomerular Filtration Rate (eGFR)",
        "Duration of Diabetes",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "##Answer:\nAge, Continuous, Gender, Ethnicity (NIH/OMB), Region of Enrollment, Diabetes duration, HbA1c, Blood pressure, eGFR, BMI, \n\n##Answer:\nAge, Categorical, Age, Continuous, Sex: Female, Male, Region of Enrollment, Diabetes Diagnosis Duration, Existing Cardiovascular Disease, Baseline HbA1c, Daily Insulin Dose, BMI, Blood Pressure, Total Cholesterol, eGFR, Diabetic Retinopathy, \n\n##Answer:\nAge, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Objective weekly MVPA minutes, Adherence to MVPA guidelines at baseline, Objective average daily steps,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex/Gender",
          "Gender"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ]
      ],
      "remaining_reference_features": [
        "Weight",
        "Pre-Enrollment Anti-Hyperglycemic Therapy"
      ],
      "remaining_candidate_features": [
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment",
        "Diabetes duration",
        "HbA1c",
        "Blood pressure",
        "eGFR",
        "BMI",
        "Categorical",
        "Sex: Female",
        "Male",
        "Diabetes Diagnosis Duration",
        "Existing Cardiovascular Disease",
        "Baseline HbA1c",
        "Daily Insulin Dose",
        "Blood Pressure",
        "Total Cholesterol",
        "Diabetic Retinopathy",
        "Body Mass Index",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Objective weekly MVPA minutes",
        "Adherence to MVPA guidelines at baseline",
        "Objective average daily steps"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes, baseline HbA1c, estimated glomerular filtration rate (eGFR), systolic blood pressure, diastolic blood pressure, history of cardiovascular disease, history of renal disease, current medications for diabetes and hypertension, smoking status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex/Gender",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ]
      ],
      "remaining_reference_features": [
        "Weight",
        "Pre-Enrollment Anti-Hyperglycemic Therapy"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "body mass index (BMI)",
        "duration of type 2 diabetes",
        "baseline HbA1c",
        "estimated glomerular filtration rate (eGFR)",
        "systolic blood pressure",
        "diastolic blood pressure",
        "history of cardiovascular disease",
        "history of renal disease",
        "current medications for diabetes and hypertension",
        "smoking status"
      ]
    }
  }
}